A Study of Reolysin For Patients With Advanced/Metastatic Breast Cancer

NCT01656538 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

81

Enrollment

NETWORK

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Paclitaxel
DRUG: Reolysin

Sponsor

Canadian Cancer Trials Group

Collaborators

[object Object]